Global Amyotrophic Lateral Sclerosis Market to Reach $1.2 Billion by 2027
Amid the COVID-19 crisis, the global market for Amyotrophic Lateral Sclerosis estimated at US$339.2 Million in the year 2020, is projected to reach a revised size of US$1.2 Billion by 2027, growing at a CAGR of 19.2% over the period 2020-2027.
The U.S. Market is Estimated at $100.6 Million, While China is Forecast to Grow at 18.4% CAGR
The Amyotrophic Lateral Sclerosis market in the U.S. is estimated at US$100.6 Million in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$199.1 Million by the year 2027 trailing a CAGR of 18.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 17.1% and 16.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 14.1% CAGR.
Select Competitors (Total 31 Featured):
Amid the COVID-19 crisis, the global market for Amyotrophic Lateral Sclerosis estimated at US$339.2 Million in the year 2020, is projected to reach a revised size of US$1.2 Billion by 2027, growing at a CAGR of 19.2% over the period 2020-2027.
The U.S. Market is Estimated at $100.6 Million, While China is Forecast to Grow at 18.4% CAGR
The Amyotrophic Lateral Sclerosis market in the U.S. is estimated at US$100.6 Million in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$199.1 Million by the year 2027 trailing a CAGR of 18.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 17.1% and 16.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 14.1% CAGR.
Select Competitors (Total 31 Featured):
- AB Science SA
- Apotex, Inc.
- Aquestive
- Biogen, Inc.
- Brainstorm Cell Therapeutics Inc.
- Cytokinetics, Inc.
- F. Hoffmann-La Roche AG
- Genervon Biopharmaceuticals LLC
- Ionis Pharmaceuticals, Inc.
- Kringle Pharma Inc.
- Mitsubishi Tanabe Pharma Corporation
- Neuralstem, Inc.
- Orion Corporation
- Orphazyme A/S
- Sanofi SA
- Treeway BV
- Valeant Pharmaceuticals International, Inc.
- ViroMed Co., Ltd.
Frequently Asked Questions about the Global Market for Amyotrophic Lateral Sclerosis
What is the estimated value of the Global Market for Amyotrophic Lateral Sclerosis?
What is the growth rate of the Global Market for Amyotrophic Lateral Sclerosis?
What is the forecasted size of the Global Market for Amyotrophic Lateral Sclerosis?
Note: Product cover images may vary from those shown
I. METHODOLOGY
II. EXECUTIVE SUMMARY
III. MARKET ANALYSIS
IV. COMPETITION
Note: Product cover images may vary from those shown